REXO2 and prostate adenocarcinoma: The results showed that all six genes (GPC6, ISYNA1, ITGAX, MGAT4B, PRR7, and REXO2), except FOXS1, were significantly highly expressed in PRAD cells (Figure 8A, p < 0.01).